Form 4 for LFVN Lifevantage Corp
Accepted 2023-11-20 00:00:00 ET · period of report 2023-11-16 · accession 0000849146-23-000222 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-20 | 2023-11-16 | LFVN | Latham Cynthia | Dir | A - Grant | $6.11 | +17.2K | 48.0K | +56% | +$105.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-16 | A | A | 17,185 | $6.11 | 47,979 | D | — | — | (F1) These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 16, 2024, subject to the reporting person's continuous service to the issuer through such date. (F2) The price reported in Column 4 is equal to the average closing price of the issuer's common stock for the ten trading days ending the day before the date of grant. |